Targeting of drugs to various blood cell types using (neo-)glycoproteins, antibodies and other protein carriersMOLEMA, G; MEIJER, D. K. F.Advanced drug delivery reviews. 1994, Vol 14, Num 1, pp 25-50, issn 0169-409XArticle

Current concepts on hepatic transport of drugsMEIJER, D. K. F.Journal of hepatology. 1987, Vol 4, Num 2, pp 259-268, issn 0168-8278Article

Effect of ethanol on hepatobiliary transport of cationic drugs. A study in the isolated perfused rat liver, rat hepatocytes and rat mitchondriaSTEEN, H; MEREMA, M; MEIJER, D. K. F et al.Journal of hepatology. 1994, Vol 21, Num 3, pp 308-314, issn 0168-8278Article

Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugsGROOTHUIS, G. M. M; MEIJER, D. K. F.Enzyme. 1992, Vol 46, Num 1-3, pp 94-138, issn 0013-9432Article

Binding of drugs with a quaternary ammonium group to alpha-1 acid glycoprotein and asialo alpha-1 acid glycoproteinVAN DER SLUIJS, P; MEIJER, D. K. F.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 3, pp 703-707, issn 0022-3565Article

The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosidesHEDMAN, A; MEIJER, D. K. F.Journal of hepatology. 1998, Vol 28, Num 2, pp 240-249, issn 0168-8278Article

Trends in the organization of drug research: interfacing industry and universitiesMEIJER, D. K. F; WILTING, J.European journal of pharmaceutics and biopharmaceutics. 1997, Vol 43, Num 3, pp 243-252, issn 0939-6411Article

Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytesHEDMAN, A; MEIJER, D. K. F.Journal of pharmaceutical sciences. 1998, Vol 87, Num 4, pp 457-461, issn 0022-3549Article

A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liverSTEEN, H; MARJOLIJN MEREMA; MEIJER, D. K. F et al.Biochemical pharmacology. 1992, Vol 44, Num 12, pp 2323-2331, issn 0006-2952Article

MW-Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoringPROOST, J. H; MEIJER, D. K. F.Computers in biology and medicine. 1992, Vol 22, Num 3, pp 155-163, issn 0010-4825Article

Hepatic transport mechanisms for bivalent organic cations. Subcellular distribution and hepato-biliary concentration gradients of some steroidal muscle relaxantsMOL, W. E. M; MEIJER, D. K. F.Biochemical pharmacology. 1990, Vol 39, Num 2, pp 383-390, issn 0006-2952Article

Structure-pharmacokinetics relationship of quaternary ammonium compounds: correlation of physicochemical and pharmacokinetic parametersNEEF, C; MEIJER, D. K. F.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 2, pp 111-118, issn 0028-1298Article

Structure-pharmacokinetics relationship of quaternary ammonium compounds: elimination and distribution characteristicsNEEF, C; OOSTING, R; MEIJER, D. K. F et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 2, pp 103-110, issn 0028-1298Article

Soluble polymers for lectin-mediated drug targetingSEYMOUR, L. W.Advanced drug delivery reviews. 1994, Vol 14, Num 1, pp 89-111, issn 0169-409XArticle

Mechanisms for the uptake of cationic drugs by the liver : a study with tributylmethylammonium (TBuMA)STEEN, H; OOSTING, R; MEIJER, D. K. F et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 258, Num 2, pp 537-543, issn 0022-3565Article

Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug deliveryMEIJER, D. K. F; VAN DER SLUITS, P.Pharmaceutical research. 1989, Vol 6, Num 2, pp 105-118, issn 0724-8741Article

Drug targeting to the kidney with low-molecular-weight proteinsFRANSSEN, E. J. F; MOOLENAAR, F; DE ZEEUW, D et al.Advanced drug delivery reviews. 1994, Vol 14, Num 1, pp 67-88, issn 0169-409XArticle

Targeting of sugar- and charge-modified albumins to fibrotic rat livers : the accessibility of hepatic cells after chronic bile duct ligationBELJAARS, L; POELSTRA, K; MOLEMA, G et al.Journal of hepatology. 1998, Vol 29, Num 4, pp 579-588, issn 0168-8278Article

Drug targeting systems for antiviral agents : options and limitationsMEIJER, D. K. F; JANSEN, R. W; MOLEMA, G et al.Antiviral research. 1992, Vol 18, Num 3-4, pp 215-258, issn 0166-3542Article

Hepatic uptake and biliary excretion of organic cations. I: Characterization of three new model compoundsNEEF, C; KEULEMANS, K. T. P; MEIJER, D. K. F et al.Biochemical pharmacology. 1984, Vol 33, Num 24, pp 3977-3990, issn 0006-2952Article

Pharmacokinetics of biliary excretion in man. VI: Indocyanine greenMEIJER, D. K. F; WEERT, B; VERMEER, G. A et al.European journal of clinical pharmacology. 1988, Vol 35, Num 3, pp 295-303, issn 0031-6970Article

Lactosylation of albumin reduces uptake rate of dibromosulfophthalein in perfused rat liver and dissociation rate from albumin in vitroVAN DER SLUIJS, P; POSTEMA, B; MEIJER, D. K. F et al.Hepatology (Baltimore, Md.). 1987, Vol 7, Num 4, pp 688-695, issn 0270-9139Article

Rectal versus oral absorption of diflunisal in manMOOLENAAR, F; PRONK, J; VISSER, J et al.International journal of pharmaceutics. 1984, Vol 19, Num 2, pp 161-167, issn 0378-5173Article

Differential effects of metabolic inhibitors on cellular and mitochondrial uptake of organic cations in rat liverSTEEN, H; MARING, J. G; MEIJER, D. K. F et al.Biochemical pharmacology. 1993, Vol 45, Num 4, pp 809-818, issn 0006-2952Article

The fate of diastereomeric glutathione conjugates of α- bromoisovalerylurea in blood in the rat in vivo and in the perfused liver. Stereoselectivity in biliary and urinary excretionPOLHUIJS, M; MEIJER, D. K. F; MULDER, G. J et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 256, Num 2, pp 458-461, issn 0022-3565, 4 p.Article